-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
HIV-1-inhibitor-30
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2132412-77-0.gif)
| Category | Human immunodeficiency Virus (HIV) |
| CAS | 2132412-77-0 |
| Description | HIV-1 inhibitor-30 (compound 10i) is a potent HIV-1 inhibitor with an EC50 value of 40 nM and an IC50 value of 80 nM for HIV-1 RT DNA polymerase. HIV-1 inhibitor-30 has highly antiretroviral activity against seven non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV-1 strains (RT-K103N; RT-Y181C; RT K103N,Y181C; RT-L100I,K103N; RT-Y188L; RT-K103N,G190A; RT-K103N,V108I) with IC50s of 0.04~1.42 μM. HIV-1 inhibitor-30 can be used for researching AIDS. |
Product Information
| Synonyms | HIV-1 inhibitor-30|2-(1-butoxyindol-3-yl)-N-(3-chloro-4-pyridyl)acetamide|CHEMBL4786649|HY-146365|CS-0498479 |
| Molecular Weight | 357.83 |
| Molecular Formula | C19H20ClN3O2 |
| Canonical SMILES | CCCCON1C=C(C2=CC=CC=C21)CC(=O)NC3=C(C=NC=C3)Cl |
| Purity | ≥98% (HPLC) |
| Solubility | 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 437 |
| Exact Mass | 357.1244046 |
| Target | EC50: 40 nM (HIV-1 WT) IC50: 80 nM (HIV-1 RT DNA polymerase) |
| XLogP3-AA | 4 |
